Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Diffuse Intrinsic Pontine Glioma 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

Cyclophosphamide 75fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 59Mycophenolic Acid 53Tacrolimus 51Whole-Body Irradiation 48Busulfan 42Antilymphocyte Serum 40Cyclosporine 38Filgrastim 32fludarabine 31Methotrexate 30Melphalan 29Radiotherapy 22Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Etoposide 16Sirolimus 14Alemtuzumab 13Flow Cytometry 12Cyclosporins 12thymoglobulin 11Granulocyte Colony-Stimulating Factor 11Cytarabine 10Psychiatric Rehabilitation 9sargramostim 8Thiotepa 8Rituximab 8Therapeutics 7Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × Fluid Therapy × Lymphoid × Clear all
NCT06013423 2026-01-22

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutchinson Cancer Center

Phase 2 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡